Patients’ Right to Know Their Medication Act of 2025

Hozzl · 2025-09-23T17:18:58Z

Explore the details of House Bill 5133 Patients’ Right to Know Their Medication Act of 2025 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

9/23/2025, 5:18 PM

Summary of Bill HR 5133

This bill, designated as H.R. 5133 in the 119th Congress, aims to amend the Federal Food, Drug, and Cosmetic Act to address requirements related to patient medication information that must be included in the labeling of prescription drugs. The bill was introduced on September 4, 2025. Further details about specific provisions, summaries, or directives are not provided in the context object.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5133

Bill HR 5133 is currently in the status of Bill Introduced since September 4, 2025. Bill HR 5133 was introduced during Congress 119 and was introduced to the House on September 4, 2025. Bill HR 5133's most recent activity was Referred to the House Committee on Energy and Commerce. as of September 4, 2025

Bipartisan Support of Bill HR 5133

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5133

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 5133

To amend the Federal Food, Drug, and Cosmetic Act regarding the patient medication information required to be included in the labeling of prescription drugs, and for other purposes.